Zenotech Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

58.70 -1.75 ▼-2.9%

27 January 2023, 04:01:00 PM
Volume: 18,642

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zenotechlab.com
Market Cap 359.47 Cr.
Enterprise Value(EV) 358.25 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 3.98 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 14.81 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 12.65 Trailing Twelve Months Ending 2022-09
Price to Book Value 4.66 Calculated using Price: 58.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 6.10 Cr. 61,030,568 Shares
FaceValue 10
Company Profile
Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.89%
1 Week
-0.51%
1 Month
-6.90%
3 Month
-12.06%
6 Month
+8.40%
1 Year
+7.12%
2 Year
+90.58%
5 Year
+22.04%
10 Year
+126.55%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -155.73 -7.73 24.35 -2.48 37.26
Return on Capital Employed (%) -39.28 -61.52 -65.68 -61.88 -5.95 18.32 0.48 15.26
Return on Assets (%) -33.32 -45.43 -32.82 -38.33 -17.89 -3.76 12.67 -1.42 26.45

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3 -27 -46 -66 42 39 50 48 71 77
Non Curr. Liab. 1 0 0 0 0 0 0 22 -4 -8
Curr. Liab. 66 91 99 116 39 45 35 15 16 15
Minority Int.
Equity & Liab. 70 64 53 51 82 85 86 86 82 85
Non Curr. Assets 59 55 50 49 50 65 80 79 74 72
Curr. Assets 11 8 3 2 31 19 6 7 7 13
Misc. Exp. not W/O
Total Assets 70 64 53 51 82 85 86 86 82 85

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 3 4 2 2 11 13 26 22 37 41
Other Income 3 0 0 0 2 5 1 0 1 1
Total Income 5 4 2 2 14 18 27 23 37 43
Total Expenditure -20 -24 -10 -13 -19 -17 -17 -16 -19 -20
PBIDT -15 -20 -8 -10 -6 1 10 7 18 22
Interest -5 -7 -8 -8 -2 0 -1 -2 -1 -1
Depreciation -4 -4 -4 -4 -4 -4 -5 -6 -7 -7
Taxation 12 10
Exceptional Items 2 6
PAT -23 -30 -19 -20 -12 -3 11 -1 22 24
Adjusted EPS -6 -8 -5 -5 -2 -1 2 0 4 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -10 -24 -8 -5 2 -16 -14 11 6 18
Cash Fr. Inv. 0 -1 0 6 -1 -3 -16 -21 -5 -2
Cash Fr. Finan. 10 30 7 -1 -1 47 15 -3 0 -16
Net Change 0 5 -1 0 0 28 -15 -12 1 0
Cash & Cash Eqvt 2 6 6 0 0 28 13 1 2 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 68.84 68.84 68.84 68.84 68.84 68.84 68.84 68.84 68.84
Public 31.16 31.16 31.16 31.16 31.16 31.16 31.16 31.16 31.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Announcement under Regulation 30 (LODR)-Meeting Updates
With reference to the intimation of Board Meeting submitted on January 19 2023 we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 27 2023 which commenced at 5:30 p.m. IST and ended at 7: 15 p.m. IST. The Board has inter-alia approved Unaudited Standalone Financial Results for the quarter and nine months ended December 31 2022. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company.
Fri, 27 Jan 2023
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2022
With reference to the intimation of Board Meeting submitted on January 19 2023 we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 27 2023 which commenced at 5:30 p.m. IST and ended at 7:15 p.m. IST. The Board has inter-alia approved Unaudited Standalone Financial Results for the quarter and nine months ended December 31 2022. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company.
Thu, 19 Jan 2023
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2022.
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2022.

Technical Scans View Details >>

Fri, 27 Jan 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Low Close Crossing Last Month Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Below Last Month Low Close Below Last Month Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Zenotech Laboratories Ltd.

What is Zenotech Laboratorie share price?
Can I buy Zenotech Laboratorie shares now?
What is the Market Cap of Zenotech Laboratorie?
What are the key metrics to analyse Zenotech Laboratorie?
What is the 52 Week High and Low of Zenotech Laboratorie?
What is the trend of Zenotech Laboratorie share price?